TVRD
Tvardi Therapeutics
TVRD
TVRD
146 hedge funds and large institutions have $563M invested in Tvardi Therapeutics in 2018 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 50 increasing their positions, 27 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
56% more capital invested
Capital invested by funds: $360M → $563M (+$203M)
12% more funds holding
Funds holding: 130 → 146 (+16)
0.03% more ownership
Funds ownership: 1.63% → 1.66% (+0.03%)
Holders
146
Holding in Top 10
4
Calls
$20.7M
Puts
$10.6M
Top Buyers
| 1 | +$46.6M | |
| 2 | +$12.4M | |
| 3 | +$9.83M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.31M |
| 5 |
NC
Nexthera Capital
New York
|
+$7.22M |
Top Sellers
| 1 | -$4.27M | |
| 2 | -$4.26M | |
| 3 | -$2.48M | |
| 4 |
Parallax Volatility Advisers
San Francisco,
California
|
-$1.97M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$1.48M |